This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henriksen, K. Articles by Karsdal, M. A. Search for Related Content PubMed PubMed Citation Articles by Henriksen, K. Articles by Karsdal, M. A.

(American Journal of Pathology. 2004;164:1537-1545.)
© 2004 American Society for Investigative Pathology

Characterization of Osteoclasts from Patients Harboring a G215R Mutation in ClC-7 Causing Autosomal Dominant Osteopetrosis Type II

Kim Henriksen^*, Jeppe Gram, Sophie Schaller^*, Bjarne H. Dahl, Morten H. Dziegiel, Jens Bollerslev^¶ and Morten A. Karsdal^*

From Nordic Bioscience,^* Herlev, Denmark; Ribe County Hospital, Esbjerg, Denmark; Neurosearch, Ballerup, Denmark; Blodbank, Copenhagen University Hospital, Østerbro, Denmark; and the Department of Medicine,^¶ Section of Endocrinology, National University Hospital, Oslo, Norway

Autosomal dominant osteopetrosis II (ADOII) is a relatively benign disorder caused by a missense mutation in the ClCN7 gene. In this study, we characterize the osteoclasts from patients with ADOII, caused by a G215R mutation, and investigate the effect on osteoclast function in vitro. Osteoclasts from ADOII patients and healthy age- and sex-matched controls, were used to evaluate osteoclastogenesis, cell fusion, acidification, and resorptive activity. ADOII osteoclasts in vivo have increased number and size. However, in vitro we observed no significant changes in the osteoclast formation rate, the morphology, and the expression of markers, such as cathepsin K and tartrate-resistant acid phosphatase. When mature ADOII osteoclasts were investigated on mineralized bone, they degraded the bone material, however only to 10 to 20% of the level in controls. We show by acridine orange, that the reduced chloride transport leads to reduced acidification. We show that the residual activity is sensitive to inhibitors of cathepsins and chloride channels, confirming that resorption is reduced but present. In conclusion, this is the first functional in vitro study of human ADOII osteoclasts. We show normal osteoclastogenesis in ADOII osteoclasts. However, the residual activity of the ClC-7 channel in ADOII osteoclasts does not allow sufficient acidification and thereby resorption.

This article has been cited by other articles:

				E. F Shead, C. S Haworth, A. M Condliffe, D. J McKeon, M. A Scott, and J. E Compston Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone Thorax, July 1, 2007; 62(7): 650 - 651. [Full Text] [PDF]

				P. Chavassieux, E. Seeman, and P. D. Delmas Insights into Material and Structural Basis of Bone Fragility from Diseases Associated with Fractures: How Determinants of the Biomechanical Properties of Bone Are Compromised by Disease Endocr. Rev., April 1, 2007; 28(2): 151 - 164. [Abstract] [Full Text] [PDF]

				U. Valcourt, B. Merle, E. Gineyts, S. Viguet-Carrin, P. D. Delmas, and P. Garnero Non-enzymatic Glycation of Bone Collagen Modifies Osteoclastic Activity and Differentiation J. Biol. Chem., February 23, 2007; 282(8): 5691 - 5703. [Abstract] [Full Text] [PDF]

				N. A. Meadows, S. M. Sharma, G. J. Faulkner, M. C. Ostrowski, D. A. Hume, and A. I. Cassady The Expression of Clcn7 and Ostm1 in Osteoclasts Is Coregulated by Microphthalmia Transcription Factor J. Biol. Chem., January 19, 2007; 282(3): 1891 - 1904. [Abstract] [Full Text] [PDF]

				M. A. Karsdal and K. Henriksen Osteoclasts Control Osteoblast Activity IBMS BoneKEy, January 1, 2007; 4(1): 19 - 24. [Full Text] [PDF]

				J. C. Edwards, C. Cohen, W. Xu, and P. H. Schlesinger c-Src Control of Chloride Channel Support for Osteoclast HCl Transport and Bone Resorption J. Biol. Chem., September 22, 2006; 281(38): 28011 - 28022. [Abstract] [Full Text] [PDF]

				A Del Fattore, B Peruzzi, N Rucci, I Recchia, A Cappariello, M Longo, D Fortunati, P Ballanti, M Iacobini, M Luciani, et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment J. Med. Genet., April 1, 2006; 43(4): 315 - 325. [Abstract] [Full Text] [PDF]

				U. Kornak, A. Ostertag, S. Branger, O. Benichou, and M.-C. de Vernejoul Polymorphisms in the CLCN7 Gene Modulate Bone Density in Postmenopausal Women and in Patients with Autosomal Dominant Osteopetrosis Type II J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 995 - 1000. [Abstract] [Full Text] [PDF]

				K. Henriksen, J. Gram, P. Hoegh-Andersen, R. Jemtland, T. Ueland, M. H. Dziegiel, S. Schaller, J. Bollerslev, and M. A. Karsdal Osteoclasts from Patients with Autosomal Dominant Osteopetrosis Type I Caused by a T253I Mutation in Low-Density Lipoprotein Receptor-Related Protein 5 Are Normal in Vitro, but Have Decreased Resorption Capacity in Vivo Am. J. Pathol., November 1, 2005; 167(5): 1341 - 1348. [Abstract] [Full Text] [PDF]

				M. A. Karsdal, K. Henriksen, M. G. Sorensen, J. Gram, S. Schaller, M. H. Dziegiel, A.-M. Heegaard, P. Christophersen, T. J. Martin, C. Christiansen, et al. Acidification of the Osteoclastic Resorption Compartment Provides Insight into the Coupling of Bone Formation to Bone Resorption Am. J. Pathol., February 1, 2005; 166(2): 467 - 476. [Abstract] [Full Text] [PDF]